Speaker: Amit K. Sachdev, FDA Deputy Commissioner

——————————————————————————

The FDA is on the road to creating a new regulatory landscape. On October 26th, Latham & Watkins LLP is pleased to host a video conference featuring Amit K. Sachdev, FDA Deputy Commissioner and John R. Manthei, Partner, Latham & Watkins. Mr. Sachdev will discuss FDA's ongoing "Critical Path" initiative, which is intended, through collaboration between FDA, industry and academia, to facilitate the modernization of the drug and device development and approval process to keep pace with scientific innovation, resulting to quicker, more cost effective product approvals. Following a brief overview by Mr. Manthei, Mr. Sachdev will discuss the initiative in detail, and field questions on this and other significant regulatory matters at FDA.

Chair: Alan Mendelson, Partner, Latham & Watkins

Overview:
John Manthei, Partner, Latham & Watkins

Date: October 26, 2004

Agenda:
Doors open: 7:30 am
Panel Discussion: 8:00-9:15 am

Continental Breakfast Included

If you are a vebture capitalist and would like to attend this event please contact Life Science SIG Chair, Alan Mendelson, Partner, Latham & Watkins through

VC Task Force was established in 2001 to create a variety of programs that provide information and insight on current strategic and tactical concerns of the venture capital community and the management of venture-backed companies. VC Task Force provides the venture capital community and their portfolio companies a forum for real-time information exchange and dialogue through panels, workshops, and roundtable meetings conducted by business/industry experts. We strive to identify and be responsive to the ongoing and changing needs of our members. The VC Task Force holds informational and networking events throughout the year to benefit its member community.